Concepedia

Bayesian Adaptive Randomization

Bayesian Adaptive Randomization is a statistical method for dynamically allocating treatments in clinical trials that uses Bayesian updating to modify assignment probabilities based on accumulating efficacy and safety data, thereby increasing the likelihood of assigning participants to better-performing interventions while maintaining randomization.

62

Publications

4.5K

Citations

519

Authors

269

Institutions

Publications per year

2017–2026

24

Parents

Publications

62

Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002

Robert G. Maki, J. Kyle Wathen, Shreyaskumar Patel et al. · Journal of Clinical Oncology · 2007 · 733 citations

, , +17

Adaptive Randomization of Neratinib in Early Breast Cancer

John W. Park, Minetta C. Liu, Douglas Yee et al. · New England Journal of Medicine · 2016 · 460 citations · Full text

, , +17

Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer

Zhongxing Liao, Ritsuko Komaki, Daniel R. Gomez et al. · Journal of Clinical Oncology · 2018 · 338 citations · Full text

, , +17

Pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer (BC): Results from I-SPY 2.

Rita Nanda, Minetta C. Liu, Christina Yau et al. · Journal of Clinical Oncology · 2017 · 208 citations

, , +17

Bayesian adaptive design for targeted therapy development in lung cancer — a step toward personalized medicine

Xian Zhou, Suyu Liu, Edward S. Kim et al. · Clinical Trials · 2008 · 206 citations · Full text

, , +17

1–5 of 62

Authors

519

  1. LT
    Lorenzo Trippa

    Dana-Farber Cancer Institute, United States

    10 publications · 538 citations

    10

    h-index

  2. DA
    Donald A. Berry

    The University of Texas MD Anderson Cancer Center, United States

    8 publications · 891 citations

    8

    h-index

  3. PF
    Peter F. Thall

    The University of Texas MD Anderson Cancer Center, United States

    7 publications · 1K citations

    7

    h-index

  4. JK
    J. Kyle Wathen

    The University of Texas MD Anderson Cancer Center, United States

    5 publications · 954 citations

    5

    h-index

  5. HC
    Howard Colman

    The University of Texas MD Anderson Cancer Center, United States

    5 publications · 149 citations

    5

    h-index

1–5 of 519

Institutions

269

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    17 h-index

    76 publications

    6.5K citations

  2. Berry & Associates (United States)

    Dexter, United States

    12 h-index

    30 publications

    2.4K citations

  3. Dana-Farber Cancer Institute

    Boston, United States

    9 h-index

    86 publications

    2.4K citations

  4. University of California, San Francisco

    San Francisco, United States

    7 h-index

    73 publications

    7.3K citations

  5. Harvard University

    Cambridge, United States

    6 h-index

    49 publications

    768 citations

  6. Huntsman Cancer Institute

    Salt Lake City, United States

    5 h-index

    5 publications

    149 citations

  7. University of Virginia

    Charlottesville, United States

    5 h-index

    7 publications

    381 citations

  8. Mayo Clinic in Arizona

    Scottsdale, United States

    5 h-index

    7 publications

    812 citations

1–8 of 269

Venues

  1. Journal of Clinical Oncology

    8 publications · 1.5K citations

    8

    h-index

  2. Clinical Trials

    7 publications · 503 citations

    7

    h-index

  3. Statistics in Medicine

    5 publications · 332 citations

    5

    h-index

  4. Journal of Biopharmaceutical Statistics

    JBS · 3 publications · 106 citations

    3

    h-index

  5. Biometrics

    2 publications · 31 citations

    2

    h-index

1–5